Cefotaxime is a third-generation parenteral cephalosporin with extended Gram-negative activity and good CNS penetration, used for meningitis, septicaemia and serious hospital-acquired infections. Simson Pharma's Cefotaxime reference standard and impurities support comprehensive stability-indicating testing for this critical-care antibiotic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefotaxime Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.